Ampio Pharmaceuticals Inc (AMPE)
0.286
-0.06
(-16.13%)
USD |
OTCM |
Apr 23, 15:32
Ampio Pharmaceuticals Free Cash Flow (Quarterly): -2.309M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.309M |
| September 30, 2023 | -0.555M |
| June 30, 2023 | -3.399M |
| March 31, 2023 | -2.301M |
| December 31, 2022 | -4.294M |
| September 30, 2022 | -5.943M |
| June 30, 2022 | -5.947M |
| March 31, 2022 | -4.944M |
| December 31, 2021 | -3.704M |
| September 30, 2021 | -3.926M |
| June 30, 2021 | -2.328M |
| March 31, 2021 | -4.228M |
| December 31, 2020 | -2.895M |
| September 30, 2020 | -2.754M |
| June 30, 2020 | -4.59M |
| March 31, 2020 | -4.553M |
| December 31, 2019 | -4.759M |
| September 30, 2019 | -4.738M |
| June 30, 2019 | -3.463M |
| March 31, 2019 | -2.445M |
| December 31, 2018 | -2.405M |
| September 30, 2018 | -3.254M |
| June 30, 2018 | -3.252M |
| March 31, 2018 | -3.793M |
| December 31, 2017 | -2.611M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.145M |
| June 30, 2017 | -3.086M |
| March 31, 2017 | -2.638M |
| December 31, 2016 | -2.581M |
| September 30, 2016 | -2.498M |
| June 30, 2016 | -4.663M |
| March 31, 2016 | -4.884M |
| December 31, 2015 | -7.767M |
| September 30, 2015 | -6.272M |
| June 30, 2015 | -5.466M |
| March 31, 2015 | -7.049M |
| December 31, 2014 | -6.508M |
| September 30, 2014 | -8.784M |
| June 30, 2014 | -12.59M |
| March 31, 2014 | -11.53M |
| December 31, 2013 | -6.033M |
| September 30, 2013 | -5.392M |
| June 30, 2013 | -5.138M |
| March 31, 2013 | -4.211M |
| December 31, 2012 | -2.598M |
| September 30, 2012 | -1.904M |
| June 30, 2012 | -2.106M |
| March 31, 2012 | -3.107M |
| December 31, 2011 | -4.133M |
| September 30, 2011 | -1.575M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.947M
Minimum
Jun 2022
-0.555M
Maximum
Sep 2023
-3.77M
Average
-3.926M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -2.003M |
| Tivic Health Systems Inc | -1.774M |
| Oragenics Inc | -1.102M |
| Actinium Pharmaceuticals Inc | -7.49M |
| MAIA Biotechnology Inc | -3.992M |